RCAN1 overexpression exacerbates calcium overloading-induced neuronal apoptosis

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Sun, Xiulian ^a,c   Wu, Yili ^b,c   Herculano, Bruno ^c   Song, Weihong ^b,c  

^a SHANDONG UNIVERSITY   (China)

^b CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CALCIUM; CASPASE 3; REGULATOR OF CALCINEURIN 1.1; REGULATOR OF CALCINEURIN 1.4; REGULATOR PROTEIN; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG; ISOPROTEIN; MUSCLE PROTEIN; NEUROTOXIN; RCAN1 PROTEIN, HUMAN; SIGNAL PEPTIDE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; NEGATIVE FEEDBACK; NERVE CELL; NERVE CELL NECROSIS; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; CELL LINE; CYTOLOGY; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; TOXICITY;

ANIMALS; APOPTOSIS; BASE SEQUENCE; CALCIUM; CASPASE 3; CELL LINE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; NEURONS; NEUROTOXINS; NFATC TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84899671123     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095471     Document Type: Article

References (56)

1. Down JLH (1866) Observations on an ethnic classification of idiots. London Hospital Reports 3: 259-262.
2. Jacobs PA, Baikie AG, Court Brown WM, Strong JA (1959) The somatic chromosomes in mongolism. Lancet 1: 710.
3. Lejeune J, Gautier M, Turpin R (1959) Study of somatic chromosomes from 9 mongoloid children. C R Hebd Seances Acad Sci 248: 1721-1722.
4. Arron JR, Winslow MM, Polleri A, Chang CP, Wu H, et al. (2006) NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 441: 595-600. (Pubitemid 43927286)
5. Klee CB, Crouch TH, Krinks MH (1979) Calcineurin: a calcium- and calmodulin-binding protein of the nervous system. Proc Natl Acad Sci U S A 76: 6270-6273. (Pubitemid 10163382)
6. Chang KT, Shi YJ, Min KT (2003) The Drosophila homolog of Down's syndrome critical region 1 gene regulates learning: implications for mental retardation. Proc Natl Acad Sci U S A 100: 15794-15799. (Pubitemid 38021069)
7. Martin KR, Corlett A, Dubach D, Mustafa T, Coleman HA, et al. (2012) Over-expression of RCAN1 causes Down syndrome-like hippocampal deficits that alter learning and memory. Human Molecular Genetics 21: 3025-3041.
8. Poppek D, Keck S, Ermak G, Jung T, Stolzing A, et al. (2006) Phosphorylation inhibits turnover of the tau protein by the proteasome: influence of RCAN1 and oxidative stress. Biochem J 400: 511-520. (Pubitemid 44974463)
9. Ermak G, Pritchard MA, Dronjak S, Niu B, Davies KJ (2011) Do RCAN1 proteins link chronic stress with neurodegeneration? FASEB J 25: 3306-3311.
10. Fuentes JJ, Pritchard MA, Planas AM, Bosch A, Ferrer I, et al. (1995) A new human gene from the Down syndrome critical region encodes a proline-rich protein highly expressed in fetal brain and heart. Hum Mol Genet 4: 1935-1944.
11. Fuentes JJ, Pritchard MA, Estivill X (1997) Genomic organization, alternative splicing, and expression patterns of the DSCR1 (Down syndrome candidate region 1) gene. Genomics 44: 358-361. (Pubitemid 27419014)
12. Harris CD, Ermak G, Davies KJ (2007) RCAN1-1L is overexpressed in neurons of Alzheimer's disease patients. FEBS J 274: 1715-1724. (Pubitemid 46426906)
13. Ermak G, Harris CD, Davies KJ (2002) The DSCR1 (Adapt78) isoform 1 protein calcipressin 1 inhibits calcineurin and protects against acute calcium-mediated stress damage, including transient oxidative stress. FASEB J 16: 814-824. (Pubitemid 34615130)
14. Belmont PJ, Tadimalla A, Chen WJ, Martindale JJ, Thuerauf DJ, et al. (2008) Coordination of growth and endoplasmic reticulum stress signaling by regulator of calcineurin 1 (RCAN1), a novel ATF6-inducible gene. The Journal of biological chemistry 283: 14012-14021.
15. Peiris H, Raghupathi R, Jessup CF, Zanin MP, Mohanasundaram D, et al. (2012) Increased expression of the glucose-responsive gene, RCAN1, causes hypoinsulinemia, beta-cell dysfunction, and diabetes. Endocrinology 153: 5212-5221.
16. Sun X, Wu Y, Chen B, Zhang Z, Zhou W, et al. (2011) Regulator of calcineurin 1 (RCAN1) facilitates neuronal apoptosis through caspase-3 activation. The Journal of biological chemistry 286: 9049-9062.
17. Wu Y, Song W (2013) Regulation of RCAN1 translation and its role in oxidative stress-induced apoptosis. FASEB J 27: 208-221.
18. Yang J, Rothermel B, Vega RB, Frey N, McKinsey TA, et al. (2000) Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circ Res 87: E61-68.
19. Minami T, Horiuchi K, Miura M, Abid MR, Takabe W, et al. (2004) Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis. J Biol Chem 279: 50537-50554. (Pubitemid 39577872)
20. Cho KO, Kim YS, Cho YJ, Kim SY (2008) Upregulation of DSCR1 (RCAN1 or Adapt78) in the peri-infarct cortex after experimental stroke. Experimental neurology 212: 85-92.
21. Bhoiwala DL, Koleilat I, Qian J, Beyer B, Hushmendy SF, et al. (2013) Overexpression of RCAN1 isoform 4 in mouse neurons leads to a moderate behavioral impairment. Neurol Res 35: 79-89.
22. Sobrado M, Ramirez BG, Neria F, Lizasoain I, Arbones ML, et al. (2012) Regulator of calcineurin 1 (Rcan1) has a protective role in brain ischemia/reperfusion injury. J Neuroinflammation 9: 48.
23. Abbasi S, Lee JD, Su B, Chen X, Alcon JL, et al. (2006) Protein kinase-mediated regulation of calcineurin through the phosphorylation of modulatory calcineurin-interacting protein 1. J Biol Chem 281: 7717-7726. (Pubitemid 43847385)
24. Abbasi S, Su B, Kellems RE, Yang J, Xia Y (2005) The essential role of MEKK3 signaling in angiotensin II-induced calcineurin/nuclear factor of activated T-cells activation. J Biol Chem 280: 36737-36746. (Pubitemid 41587753)
25. Hilioti Z, Gallagher DA, Low-Nam ST, Ramaswamy P, Gajer P, et al. (2004) GSK-3 kinases enhance calcineurin signaling by phosphorylation of RCNs. Genes Dev 18: 35-47. (Pubitemid 38090686)
26. Vega RB, Yang J, Rothermel BA, Bassel-Duby R, Williams RS (2002) Multiple domains of MCIP1 contribute to inhibition of calcineurin activity. J Biol Chem 277: 30401-30407.
27. Jung MS, Park JH, Ryu YS, Choi SH, Yoon SH, et al. (2011) Regulation of RCAN1 protein activity by Dyrk1A protein-mediated phosphorylation. The Journal of biological chemistry 286: 40401-40412.
28. Chan B, Greenan G, McKeon F, Ellenberger T (2005) Identification of a peptide fragment of DSCR1 that competitively inhibits calcineurin activity in vitro and in vivo. Proc Natl Acad Sci U S A 102: 13075-13080. (Pubitemid 41324981)
29. Rothermel BA, McKinsey TA, Vega RB, Nicol RL, Mammen P, et al. (2001) Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc Natl Acad Sci U S A 98: 3328-3333. (Pubitemid 32220845)
30. Fuentes JJ, Genesca L, Kingsbury TJ, Cunningham KW, Perez-Riba M, et al. (2000) DSCR1, overexpressed in Down syndrome, is an inhibitor of calcineurin-mediated signaling pathways. Hum Mol Genet 9: 1681-1690. (Pubitemid 30427005)
31. Zanin MP, Mackenzie KD, Peiris H, Pritchard MA, Keating DJ (2013) RCAN1 regulates vesicle recycling and quantal release kinetics via effects on calcineurin activity. Journal of neurochemistry 124: 290-299.
32. Keating DJ, Dubach D, Zanin MP, Yu Y, Martin K, et al. (2008) DSCR1/RCAN1 regulates vesicle exocytosis and fusion pore kinetics: implications for Down syndrome and Alzheimer's disease. Human molecular genetics 17: 1020-1030. (Pubitemid 351426036)
33. Wang W, Zhu JZ, Chang KT, Min KT (2012) DSCR1 interacts with FMRP and is required for spine morphogenesis and local protein synthesis. The EMBO journal 31: 3655-3666.
34. Ermak G, Hench KJ, Chang KT, Sachdev S, Davies KJ (2009) Regulator of calcineurin (RCAN1-1L) is deficient in Huntington disease and protective against mutant huntingtin toxicity in vitro. The Journal of biological chemistry 284: 11845-11853.
35. Ermak G, Sojitra S, Yin F, Cadenas E, Cuervo AM, et al. (2012) Chronic Expression of RCAN1-1L Protein Induces Mitochondrial Autophagy and Metabolic Shift from Oxidative Phosphorylation to Glycolysis in Neuronal Cells. Journal of Biological Chemistry 287: 14088-14098.
36. Ma H, Xiong H, Liu T, Zhang L, Godzik A, et al. (2004) Aggregate formation and synaptic abnormality induced by DSCR1. J Neurochem 88: 1485-1496. (Pubitemid 38366925)
37. Xing L, Salas M, Zhang H, Gittler J, Ludwig T, et al. (2013) Creation and characterization of BAC-transgenic mice with physiological overexpression of epitope-tagged RCAN1 (DSCR1). Mammalian genome: official journal of the International Mammalian Genome Society 24: 30-43.
38. Baek KH, Zaslavsky A, Lynch RC, Britt C, Okada Y, et al. (2009) Down's syndrome suppression of tumour growth and the role of the calcineurin inhibitor DSCR1. Nature.
39. Porta S, Serra S, Huch M, Valverde MA, Llorens F, et al. (2007) RCAN1 (DSCR1) increases neuronal susceptibility to oxidative stress: a potential pathogenic process in neurodegeneration. Hum Mol Genet.
40. Marcus DL, Thomas C, Rodriguez C, Simberkoff K, Tsai JS, et al. (1998) Increased peroxidation and reduced antioxidant enzyme activity in Alzheimer's disease. Exp Neurol 150: 40-44. (Pubitemid 28146421)
41. Arlt S, Beisiegel U, Kontush A (2002) Lipid peroxidation in neurodegeneration: new insights into Alzheimer's disease. Curr Opin Lipidol 13: 289-294. (Pubitemid 34592286)
42. Iannello RC, Crack PJ, de Haan JB, Kola I (1999) Oxidative stress and neural dysfunction in Down syndrome. J Neural Transm Suppl 57: 257-267.
43. de Haan JB, Susil B, Pritchard M, Kola I (2003) An altered antioxidant balance occurs in Down syndrome fetal organs: implications for the "gene dosage effect" hypothesis. J Neural Transm Suppl: 67-83. (Pubitemid 38339923)
44. Busciglio J, Yankner BA (1995) Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 378: 776-779. (Pubitemid 26004408)
45. Yoeli-Lerner M, Yiu GK, Rabinovitz I, Erhardt P, Jauliac S, et al. (2005) Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol Cell 20: 539-550. (Pubitemid 41668639)
46. Jauliac S, Lopez-Rodriguez C, Shaw LM, Brown LF, Rao A, et al. (2002) The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat Cell Biol 4: 540-544. (Pubitemid 34752442)
47. Macian F, Garcia-Rodriguez C, Rao A (2000) Gene expression elicited by NFAT in the presence or absence of cooperative recruitment of Fos and Jun. EMBO J 19: 4783-4795.
48. Northrop JP, Ho SN, Chen L, Thomas DJ, Timmerman LA, et al. (1994) NFAT components define a family of transcription factors targeted in T-cell activation. Nature 369: 497-502.
49. Ly PT, Wu Y, Zou H, Wang R, Zhou W, et al. (2013) Inhibition of GSK3beta-mediated BACE1 expression reduces Alzheimer-associated phenotypes. J Clin Invest 123: 224-235.
50. Sun X, He G, Song W (2006) BACE2, as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome. Faseb J 20: 1369-1376. (Pubitemid 44943845)
51. Jain J, McCaffrey PG, Miner Z, Kerppola TK, Lambert JN, et al. (1993) The Tcell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature 365: 352-355. (Pubitemid 23288978)
52. Chen L, Glover JN, Hogan PG, Rao A, Harrison SC (1998) Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA. Nature 392: 42-48. (Pubitemid 28150581)
53. Stadelmann C, Deckwerth TL, Srinivasan A, Bancher C, Bruck W, et al. (1999) Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. Am J Pathol 155: 1459-1466.
54. Eckert A, Marques CA, Keil U, Schussel K, Muller WE (2003) Increased apoptotic cell death in sporadic and genetic Alzheimer's disease. Ann N Y Acad Sci 1010: 604-609. (Pubitemid 38265054)
55. Friedlander RM (2003) Apoptosis and caspases in neurodegenerative diseases. N Engl J Med 348: 1365-1375.
56. Vega RB, Rothermel BA, Weinheimer CJ, Kovacs A, Naseem RH, et al. (2003) Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy. Proc Natl Acad Sci U S A 100: 669-674. (Pubitemid 36126110)